Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- Vijoice (alpelisib)
- zolpidem
Interactions between your drugs
zolpidem alpelisib
Applies to: zolpidem, Vijoice (alpelisib)
Alpelisib may decrease the blood levels and effects of zolpidem. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
zolpidem food
Applies to: zolpidem
You should avoid the use of alcohol while being treated with zolpidem. Alcohol can increase the nervous system side effects of zolpidem such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. Taking zolpidem with food may delay the onset of sleep. For faster sleep onset, zolpidem should not be taken with or immediately after a meal. This will make it easier for your body to absorb the medication. Talk to your doctor or pharmacist if you have any questions or concerns.
alpelisib food
Applies to: Vijoice (alpelisib)
Food significantly enhances the absorption of alpelisib. You should take each dose of alpelisib at the same time each day with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication. Talk to your doctor if you have questions or have difficulty taking alpelisib with food. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Piqray
Piqray (alpelisib) is used to treat breast cancer that has a PIK3CA gene mutation. Piqray is a ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Itovebi
Itovebi (inavolisib) is used to treat breast cancer that is HR-positive, HER-negative, and has an ...
Joenja
Joenja (leniolisib) is used for the treatment of activated phosphoinositide 3-kinase delta syndrome ...
Zydelig
Zydelig (idelalisib) is used to treat chronic lymphocytic leukemia, and lymphoma. Includes Zydelig ...
Leniolisib
Leniolisib systemic is used for activated pi3k-delta syndrome
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.